Structures by: Ohsawa A.
Total: 8
C[4]pAP(Hex4)
C56H76N4O4,2(C3H8O)
Organic & biomolecular chemistry (2018) 16, 44 8505-8512
a=19.493(5)Å b=17.572(5)Å c=8.547(2)Å
α=90° β=93.428(4)° γ=90°
C[4]pAP(iBt-mBzl-iBt-mBzl)
C56H60N4O6,3(CHCl3)
Organic & biomolecular chemistry (2018) 16, 44 8505-8512
a=40.5482(9)Å b=5.74900(10)Å c=26.1364(7)Å
α=90° β=105.526(2)° γ=90°
2,4-dioxido-1,2,3,4-benzotetrazine-2,4-diium
C6H4N4O2
Acta Crystallographica Section C (1992) 48, 7 1237-1239
a=13.6020(10)Å b=14.477(2)Å c=6.9690(10)Å
α=90° β=90° γ=90°
2-phenylpyridazino[2,1-f][1,2,4]triazin-4-one
C12H8N4O
Acta Crystallographica Section C (1992) 48, 6 1152-1154
a=19.057(7)Å b=7.473(3)Å c=7.286(3)Å
α=90.0° β=94.76(3)° γ=90.0°
2-phenylpyrazino[3,2-f][1,2,4]triazin-4-one
C12H8N4O
Acta Crystallographica Section C (1992) 48, 6 1152-1154
a=14.452(2)Å b=10.2570(10)Å c=7.048(3)Å
α=90.0° β=98.11(2)° γ=90.0°
2-methyl-4,6-diphenyl-1,2,3-triazinium iodide
C16H14N31,I1
Acta Crystallographica Section C (1992) 48, 5 964-965
a=18.234(2)Å b=11.9840(10)Å c=7.4680(10)Å
α=90.0° β=113.95(2)° γ=90.0°
3,4,5,8,9,10-hexamethyl-1,2,5,8-dithiadiazecine-6,7(5H,8H)- dione
C12H18N2O2S2
Acta Crystallographica Section C (1993) 49, 8 1514-1517
a=11.015(3)Å b=12.8700(10)Å c=10.5750(10)Å
α=90.0° β=94.780(10)° γ=90.0°
11,14-dimethyl-dibenzo[c,i][1,2,5,8]dithiadiazecine- 12,13(11H,14H)-dione
C16H14N2O2S2
Acta Crystallographica Section C (1993) 49, 8 1514-1517
a=27.229(3)Å b=7.6490(10)Å c=7.3580(10)Å
α=90.0° β=90.82(2)° γ=90.0°